Substantial recent advances in DNA sequencing and additional genomic technologies have played a major role in the elucidation of many of the genetic mechanisms of acquired drug resistance ...
Molecularly targeted therapies have shown promise in the management of patients with advanced cancers, often resulting in dramatic tumor responses and extending lives. However, such therapies are ...
The FDA will decide on new drugs for rosacea, AADC deficiency, breast cancer, transthyretin amyloid cardiomyopathy, and biliary tract cancer.
The FDA approved amivantamab-vmjw plus chemotherapy for locally advanced or metastatic non–small cell lung cancer (NSCLC) that harbors EGFR exon 19 deletions or exon 21 L858R substitution mutations ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback